1. Breast Cancer, Diabetes Mellitus and Glucagon-Like Peptide-1 Receptor Toward Exploring Their Possible Associations
   Naoko Hashimoto Takigami et al, 2021, Breast Cancer Research and Treatment CrossRef
2. Glucagon-like peptide 1 in health and disease
   Andreas Andersen et al, 2018, Nature Reviews Endocrinology CrossRef
3. CD26/DPP-4: Type 2 Diabetes Drug Target with Potential Influence on Cancer Biology
   Emi Kawakita et al, 2021, Cancers CrossRef
4. A real‐world disproportionality analysis of semaglutide: Post‐marketing pharmacovigilance data
   Yikuan Du et al, 2024, Journal of Diabetes Investigation CrossRef
5. GLP-1 Receptor Agonists: A Promising Therapy for Modern Lifestyle Diseases with Unforeseen Challenges
   Patrycja Kupnicka et al, 2024, Pharmaceuticals CrossRef
6. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer
   Julien Bezin et al, 2023, Diabetes Care CrossRef
7. Cancer related safety with SGLT2-i and GLP1-RAs: Should we worry?
   M. Gallo et al, 2023, Diabetes Research and Clinical Practice CrossRef
8. Application of glucagon-like peptide-1 receptor antagonists in fibrotic diseases
   Fuxun Yang et al, 2022, Biomedicine & Pharmacotherapy CrossRef
9. Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging
   Andrew Smith et al, 2019, Journal of Proteomics CrossRef
10. Challenges in the management of people with diabetes and cancer
    T. A. Chowdhury et al, 2019, Diabetic Medicine CrossRef
11. Diagnostic significance of apical membranous and cytoplasmic dot-like CD26 expression in encapsulated follicular variant of papillary thyroid carcinoma: a useful marker for capsular invasion
    Shoji Takagi et al, 2020, Endocrine Journal CrossRef
12. Revisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor Activation
    Brent A McLean et al, 2021, Endocrine Reviews CrossRef
13. Protein overexpression of toll‑like receptor 4 and myeloid differentiation factor 88 in oral squamous cell carcinoma and clinical significance
    Lili Li et al, 2021, Oncology Letters CrossRef
14. Cancer biology in diabetes update: Focusing on antidiabetic drugs
    Emi Kawakita et al, 2024, Journal of Diabetes Investigation CrossRef
15. The role of incretins and incretin-based drugs in autoimmune diseases
    Shabnam Radbakhsh et al, 2021, International Immunopharmacology CrossRef